期刊文献+

从肿瘤转移相关因子探讨非小细胞肺癌气虚血瘀证的病理基础 被引量:10

Pathological Basis of Qi-deficiency and Blood Stasis Syndrome in Patients with Non-small Cell Lung Cancer Viewing from Tumor Metastasis Related Factors
暂未订购
导出
摘要 目的观察非小细胞肺癌气虚血瘀证患者外周血中肿瘤转移相关因子的表达情况。方法随机抽取ⅡB~Ⅲ期非小细胞肺癌患者80例,将入选患者,严格按照中医气虚血瘀证诊断标准,分别归入气虚血瘀证组(40例)和非气虚血瘀证组(40例);采用酶联免疫法(ELISA)检测血清血管内皮生长因子(VEGF)、内皮抑素(Endostatin)及可溶性细胞间黏附分子-1(sICAM-1)含量;采用流式细胞仪技术检测外周血黏附分子CD44(CD44)的表达。结果气虚血瘀证组患者的外周血CD44(136.65±29.60)、血清VEGF[(1002.78±312.08)ng/L]、Endostatin[(120.88±20.00)μg/L]、sICAM-1[(531.78±213.37)μg/L]表达均高于非气虚血瘀证组[分别为98.46±20.64、(653.18±318.99)ng/L、(98.29±23.92)μg/L及(409.36±167.65)μg/L],两组比较,差异均有统计学意义(P<0.01)。结论非小细胞肺癌气虚血瘀证与肿瘤转移相关因子存在客观的内在联系;外周血CD44、血清VEGF、Endostatin、sICAM-1的检测可作为气虚血瘀证的微观辨证依据。 Objective To observe the expressions of tumor metastasis related factors(TMRF)in peripheral blood of patients with non-small cell lung cancer(NSCLC)for exploring the molecular mechanism for genesis of qi-deficiency and blood stasis(QDBS)syndrome in patients.Methods Eighty selected NSCLC patients of stage ⅡB/Ⅲ were differentiated into the QDBS group and the non-QDBS group according to the Chinese medicine syndrome differentiation criteria,40 in each group.The serum levels of vascular endothelial growth factor(VEGF),endostatin(ES)and soluble intercellular adhesive molecule-1(sICAM-1)in patients were detected by ELISA,and the expression of adhesive molecule CD44 in peripheral blood was determined using flow cytometry.Results Serum levels of VEGF(1002.78±312.08 ng/L),ES(120.88±20.00 μg/L),sICAM-1(531.78±213.37 μg/L)and CD44(136.65±29.60)were significantly higher in patients of QDBS group than in patients of non-QDBS group(653.18±318.99 ng/L,98.29±23.92 μg/L,409.36±167.65 μg/L and 98.46±20.64,respectively,P〈0.01).Conclusion Objective inner links are found between the QDBS syndrome and TMRF in NSCLC patients;serum levels of VEGF,ES,sICAM-1 and CD44 can be served as the microcosmic basis for QDBS syndrome differentiation.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2009年第10期886-888,共3页 Chinese Journal of Integrated Traditional and Western Medicine
关键词 气虚血瘀证 非小细胞肺癌 肿瘤转移相关因子 qi-deficiency and blood stasis syndrome non-small cell lung cancer tumor metastasis related factors
  • 相关文献

参考文献6

二级参考文献36

  • 1郁仁存,彭晓梅,饶协卿,王笑民,胡玉芳,王禹堂,关天瑜,张建华,吉惠敏,冯灵娟,厚常喜.固本祛瘀Ⅰ号配合化疗治疗恶性肿瘤的临床及实验研究[J].中国中西医结合杂志,1994,14(7):392-395. 被引量:36
  • 2刘嘉湘,李涌健,高虹,陈善香,韩明权.40例晚期非小细胞肺癌患者T细胞亚群及NK细胞活性[J].肿瘤,1989,9(3):109-111. 被引量:20
  • 3[1]Gabrilovich DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells[J]. Nat Med, 1996,2(10):1096-1103.
  • 4[2]Matsuyama W, Hashiguchi T, Mizoguchi A, et al. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer[J]. Chest, 2000,118(4):948-951.
  • 5[3]Ohta Y, Watanabe Y, Murakami S, et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer[J]. Br J Cancer, 1997,76(8):1041-1045.
  • 6[4]Guidi A J, Fischer L, Harris JR, et al. Microvessel density and distribution in ductal carcinoma in situ of the breast[J]. J Natl Cancer Inst, 1994,86(8):614-619.
  • 7[5]Ohta Y, Watanabe Y, Tabata T, et al. Inhibition of lymph node metastasis by an anti-angiogenic agent,TNP-470 [J].Br J Cancer, 1997, 75(4): 512-515.
  • 8[6]Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyper-permeability, and angiogenesis [J]. Am J Pathol, 1995,146(5):1029-1039.
  • 9[2]Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science,1989,246(4935):1306-1309.
  • 10[3]Wu Z, O'Reilly MS, Folkman J, et al. Suppression of tumor growth with recombinant murine angiostatin. Biochem Biophys Res Commun,1997,236(3):651-654.

共引文献106

同被引文献170

引证文献10

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部